Inspire Medical Systems, Inc.

For the period ended Sep 30, 2026. Filed Nov 2, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 2, 2026

INSP$64.33+0.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Statements of Operations

Consolidated Statements of Operations (unaudited)

(in thousands, except share and per share amounts)

	Three Months EndedSeptember 30,		Nine Months EndedSeptember 30,
	2026	2025	2026	2025
Revenue	$206,695	$224,501	$611,859	$642,904
Cost of goods sold	28,837	31,773	85,630	97,154
Gross profit	177,858	192,728	526,229	545,750
Operating expenses:
Research and development	22,176	24,211	72,700	78,223
Selling, general and administrative	184,398	158,873	483,877	462,684
Total operating expenses	206,574	183,084	556,577	540,907
Operating (loss) income	(28,716)	9,644	(30,348)	4,843
Interest and dividend (income), net	(3,897)	(3,973)	(11,377)	(13,521)
Other expense, net	191	66	527	2,986
(Loss) earnings before income taxes	(25,010)	13,551	(19,498)	15,378
Income tax (benefit) expense	(616)	3,619	15,876	6,046
Net (loss) earnings	$(24,394)	$9,932	$(35,374)	$9,332
Basic (loss) earnings per share	$(0.84)	$0.34	$(1.23)	$0.32
Diluted (loss) earnings per share	$(0.84)	$0.34	$(1.23)	$0.31
Weighted average shares outstanding:
Basic	28,929,352	29,332,376	28,822,985	29,512,495
Diluted	28,929,352	29,600,223	28,822,985	29,938,246

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.